SIC 2835 – In Vitro and In Vivo Diagnostic Substances
Valuation | |
---|---|
Market Cap ($M) | 39.12 |
Enterprise Value ($M) | 50.11 |
Book Value ($M) | 26.01 |
Book Value / Share | 3.32 |
Price / Book | 1.50 |
NCAV ($M) | -7.35 |
NCAV / Share | -0.94 |
Price / NCAV | -5.33 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.14 |
Return on Assets (ROA) | -0.13 |
Return on Equity (ROE) | -0.21 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.87 |
Current Ratio | 2.73 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 11.47 |
Assets | 43.81 |
Liabilities | 18.82 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 17.47 |
Operating Income | -5.75 |
Net Income | -5.78 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -4.67 |
Cash from Investing | -1.89 |
Cash from Financing | 1.75 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
997 | 10,404 | 9.58 | |
402 | 28,673 | 1.40 | |
811 | 13,232 | 6.13 | |
471 | 3,534 | 13.33 | |
(click for more detail) |
Similar Companies | |
---|---|
HOOK – HOOKIPA Pharma Inc. | HOTH – Hoth Therapeutics, Inc. |
HRTX – Heron Therapeutics, Inc. | IKT – Inhibikase Therapeutics, Inc. |
IMCC – IM Cannabis Corp. |
Financial data and stock pages provided by
Fintel.io